Kustikova OS - Search Results

1

EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.

Konantz M, André MC, Ebinger M, Grauer M, Wang H, Grzywna S, Rothfuss OC, Lehle S, Kustikova OS, Salih HR, Handgretinger R, Fend F, Baum C, Kanz L, Quintanilla-Martinez L, Schulze-Osthoff K, Essmann F, Lengerke C. Konantz M, et al. Among authors: kustikova os. Leukemia. 2013 Jan;27(1):56-65. doi: 10.1038/leu.2012.211. Epub 2012 Jul 25. Leukemia. 2013. PMID: 22828445

2

Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells.

Kustikova OS, Schwarzer A, Stahlhut M, Brugman MH, Neumann T, Yang M, Li Z, Schambach A, Heinz N, Gerdes S, Roeder I, Ha TC, Steinemann D, Schlegelberger B, Baum C. Kustikova OS, et al. Leukemia. 2013 Apr;27(5):1127-38. doi: 10.1038/leu.2012.355. Epub 2012 Dec 5. Leukemia. 2013. PMID: 23212151

3

Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.

Meyer J, Rhein M, Schiedlmeier B, Kustikova O, Rudolph C, Kamino K, Neumann T, Yang M, Wahlers A, Fehse B, Reuther GW, Schlegelberger B, Ganser A, Baum C, Li Z. Meyer J, et al. Leukemia. 2007 Oct;21(10):2171-80. doi: 10.1038/sj.leu.2404882. Epub 2007 Aug 2. Leukemia. 2007. PMID: 17673903

4

Retroviral integration site analysis in hematopoietic stem cells.

Kustikova OS, Baum C, Fehse B. Kustikova OS, et al. Methods Mol Biol. 2008;430:255-67. doi: 10.1007/978-1-59745-182-6_18. Methods Mol Biol. 2008. PMID: 18370305

5

The genomic risk of somatic gene therapy.

Kustikova O, Brugman M, Baum C. Kustikova O, et al. Semin Cancer Biol. 2010 Aug;20(4):269-78. doi: 10.1016/j.semcancer.2010.06.003. Epub 2010 Jul 1. Semin Cancer Biol. 2010. PMID: 20600920 Review.

6

Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.

Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Baum C, et al. Hum Gene Ther. 2006 Mar;17(3):253-63. doi: 10.1089/hum.2006.17.253. Hum Gene Ther. 2006. PMID: 16544975 Review.

7

Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.

Li Z, Kustikova OS, Kamino K, Neumann T, Rhein M, Grassman E, Fehse B, Baum C. Li Z, et al. Among authors: kustikova os. Ann N Y Acad Sci. 2007 Jun;1106:95-113. doi: 10.1196/annals.1392.003. Epub 2007 Mar 29. Ann N Y Acad Sci. 2007. PMID: 17395733

8

Dose response and clonal variability of lentiviral tetracycline-regulated vectors in murine hematopoietic cells.

Kustikova OS, Stahlhut M, Ha TC, Scherer R, Schambach A, Baum C. Kustikova OS, et al. Exp Hematol. 2014 Jul;42(7):505-515.e7. doi: 10.1016/j.exphem.2014.03.004. Epub 2014 Mar 24. Exp Hematol. 2014. PMID: 24674753 Free article.

9

Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.

Kustikova OS, Schiedlmeier B, Brugman MH, Stahlhut M, Bartels S, Li Z, Baum C. Kustikova OS, et al. Mol Ther. 2009 Sep;17(9):1537-47. doi: 10.1038/mt.2009.134. Epub 2009 Jun 16. Mol Ther. 2009. PMID: 19532134 Free PMC article.

10

Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells.

Maetzig T, Brugman MH, Bartels S, Heinz N, Kustikova OS, Modlich U, Li Z, Galla M, Schiedlmeier B, Schambach A, Baum C. Maetzig T, et al. Among authors: kustikova os. Blood. 2011 Mar 17;117(11):3053-64. doi: 10.1182/blood-2010-08-303222. Epub 2011 Jan 19. Blood. 2011. PMID: 21248062 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters